相关实验视频

Updated: May 23, 2025

Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development

Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development

Published on: March 5, 2017

双基因组工程创造同源诱导的多能干细胞,模拟亨廷顿病

Hikaru Kurasawa^1,2, Yuta Matsuura¹, Riho Yamane¹

¹School of Life Science and Technology, Institute of Science Tokyo.

Genes & genetic systems

|March 9, 2025

概括

研究人员使用诱导多能干细胞 (iPSC) 创建了亨廷顿病 (HD) 模型,并使用了一种新的双基因编辑系统. 这种技术精确地修改了polyQ重复数,以准确的疾病建模.

科学领域:

干细胞生物学干细胞生物学
遗传学是一个遗传学.
神经退行性疾病神经退行性疾病

背景情况:

亨廷顿病 (HD) 是一种致命的自体主导神经退行性疾病.
准确的HD病变发生模型需要对相关细胞类型进行精确的基因操纵.
诱导多能干细胞 (iPSCs) 为疾病建模提供了一个有价值的平台.

研究的目的:

开发一种强大的方法来产生亨廷顿病 (HD) 模拟诱导多能干细胞 (iPSCs).
建立一种基因组工程技术,使iPSCs能够精确地进行双基改造.
为研究HD创建具有不同多Q重复长度的同源IPSC线路.

主要方法:

开发基因特异性通用敲进系统 (asUKiS),一种基于同源重组的技术.
在健康的捐赠iPSC中应用asUKiS用于无痕的,基因对基因替代的polyQ重复区域和周围的基因修饰剂.
产生五个不同的iPSC线条,具有受控的polyQ重复数,并通过异位基因特异型定型验证.

主要成果:

成功生成了五个亨廷顿病 (HD) 模拟诱导多能干细胞 (iPSC) 线的成功生成.
展示asUKiS系统对精确双基因编辑的能力.
工程细胞系的验证证实了polyQ重复长度的准确修改.

结论:

asUKiS系统提供了一个强大的工具,用于为疾病建模生成精确设计的同位素iPSC线路.
在iPSCs中的双基修饰将遗传背景噪声降到最低,为研究HD等自体主导疾病提供了优势.
这种方法有助于研究亨廷顿病和潜在的其他遗传疾病中的基因型-表型相关性.

关键词:

自体主导性疾病自体主导性疾病双基因基因组工程双基因基因组工程疾病建模细胞模型亨廷顿病就是亨廷顿病.诱导的多能干细胞干细胞.

更多相关视频

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

相关概念视频

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...